Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression

Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model

(2013) Junchao Duan et al.   BIOMATERIALS

Nanoparticles in cancer therapy and diagnosis

(2012) Irène Brigger et al.   ADVANCED DRUG DELIVERY REVIEWS

Nonenzymatic glucose sensor based on CuO microfibers composed of CuO nanoparticles

(2012) Fei Cao et al.   ANALYTICA CHIMICA ACTA

Copper Complexes as Anticancer Agents

(2012) Cristina Marzano et al.   Anti-Cancer Agents in Medicinal Chemistry

Nanomedicine

(2012) Frank Caruso et al.   CHEMICAL SOCIETY REVIEWS

Reduced Graphene Oxide Conjugated Cu2O Nanowire Mesocrystals for High-Performance NO2 Gas Sensor

(2012) Suzi Deng et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling

(2012) M. L. Turski et al.   MOLECULAR AND CELLULAR BIOLOGY

Zinc oxide nanoflowers make new blood vessels

(2012) Ayan Kumar Barui et al.   Nanoscale

Effects of Cu2O nanoparticle and CuCl2 on zebrafish larvae and a liver cell-line

(2011) Dongshi Chen et al.   AQUATIC TOXICOLOGY

Cuprous oxide nanoparticles dispersed on reduced graphene oxide as an efficient electrocatalyst for oxygen reduction reaction

(2011) Xiao-Yan Yan et al.   CHEMICAL COMMUNICATIONS

Multifunctional nanoparticles for multimodal imaging and theragnosis

(2011) Dong-Eun Lee et al.   CHEMICAL SOCIETY REVIEWS

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

(2011) M. K. Gule et al.   CLINICAL CANCER RESEARCH

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

(2011) M. Zillhardt et al.   CLINICAL CANCER RESEARCH

Nanomedicine, nanotechnology in medicine

(2011) Patrick Boisseau et al.   COMPTES RENDUS PHYSIQUE

Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway

(2011) Shun Li et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell

(2011) Xiaoli Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action

(2011) Markus Meissner et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge

(2011) Rochelle R. Arvizo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor

(2011) Dong Hyun Jo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Vascular endothelial growth factor receptor-2 in breast cancer

(2010) Shanchun Guo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation

(2010) Jin Hyoung Kim et al.   BIOMATERIALS

Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation

(2010) S. Pirotte et al.   BLOOD

Extracellular Protease ADAMTS9 Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis

(2010) P. H. Y. Lo et al.   CANCER RESEARCH

Gold nanoparticles: opportunities and challenges in nanomedicine

(2010) Rochelle Arvizo et al.   Expert Opinion on Drug Delivery

Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells

(2010) Wu et al.   International Journal of Nanomedicine

Silver nano — A trove for retinal therapies

(2010) Kalimuthu Kalishwaralal et al.   JOURNAL OF CONTROLLED RELEASE

Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells

(2010) Sirin A I Adham et al.   LABORATORY INVESTIGATION

Antiangiogenic properties of silver nanoparticles

(2009) Sangiliyandi Gurunathan et al.   BIOMATERIALS

The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles

(2009) Sardarpasha Sheikpranbabu et al.   BIOMATERIALS

The stimulation of angiogenesis and collagen deposition by copper

(2009) Catherine Gérard et al.   BIOMATERIALS

Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells

(2009) Kalimuthu Kalishwaralal et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasome

(2009) Sarmad Sahiel Hindo et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer

(2009) Dimitrios H Roukos et al.   Expert Review of Anticancer Therapy

Adverse effects of anticancer agents that target the VEGF pathway

(2009) Helen X. Chen et al.   Nature Reviews Clinical Oncology

Cell cycle kinases as therapeutic targets for cancer

(2009) Silvia Lapenna et al.   NATURE REVIEWS DRUG DISCOVERY

Cuprous oxide nanospheres as probes for light scattering imaging analysis of live cells and for conformation identification of proteins

(2009) Wen Jing Qi et al.   TALANTA

Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells

(2009) Sardarpasha Sheikpranbabu et al.   JOURNAL OF NANOBIOTECHNOLOGY

Biological properties of “naked” metal nanoparticles☆

(2008) R BHATTACHARYA et al.   ADVANCED DRUG DELIVERY REVIEWS

New Roles for Copper Metabolism in Cell Proliferation, Signaling, and Disease

(2008) Michelle L. Turski et al.   JOURNAL OF BIOLOGICAL CHEMISTRY